Stockreport

Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront

Blackstone Inc.  (BX) 
Last blackstone inc. earnings: 4/23 06:56 am Check Earnings Report
PDF The deal affirms Blackstone’s vision of building companies around innovative products to meet unmet patient needs CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone Life S [Read more]